Sign in

CIK 0001645460 · Non-accelerated filer<br>Smaller reporting company

Cue Biopharma, Inc.

Sign in to watch
Ticker
CUE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
473324577
Phone
617-949-2680
Business address
100 CHESTNUT STREET, SUITE 300, SOMERVILLE, MA, 02143
Former names
Imagen Biopharma, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$389,304
in 3 filings

Net −$389,304. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Lin Shao-Lee −$305K Chief Executive Officer sold 2% of stake
  2. Ray Sumita −$52K Chief Legal Compliance Officer sold 2% of stake
  3. Meluzio Michael Vincent −$32K VP, Prin. Accounting Officer sold 2% of stake

Reading 20 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-01-20 Pienta Kenneth Chief Medical Officer Option exercise +2,720 $2.86 $8K 4,720
2021-01-20 Pienta Kenneth Chief Medical Officer Sale −2,720 $15.07 $41K 2,000
2021-01-20 Pienta Kenneth Chief Medical Officer Option exercise · Stock Option (right to buy) −2,720 17,280
2021-01-20 Pienta Kenneth Chief Medical Officer Purchase +2,720 $15.07 $41K 4,720
2021-01-04 Simon Barry J. Director Grant or award · Stock Option (right to buy) +10,000 10,000
2021-01-04 Kiener Peter A Director Grant or award · Stock Option (right to buy) +10,000 10,000
2021-01-04 DRISCOLL FREDERICK W Director Grant or award · Stock Option (right to buy) +10,000 10,000
2021-01-04 Morich Frank Director Grant or award · Stock Option (right to buy) +10,000 10,000
2021-01-04 Fletcher Aaron G.L. Director Grant or award · Stock Option (right to buy) +10,000 10,000
2021-01-04 Gray Cameron Director Grant or award · Stock Option (right to buy) +10,000 10,000
2021-01-04 HOWSON TAMAR D Director Grant or award · Stock Option (right to buy) +10,000 10,000
2020-11-24 Fletcher Aaron G.L. Director Purchase +6,548 $12.64 $83K 165,000
2020-10-05 Suri Anish President and CSO Shares withheld for taxes −9,800 $16.30 $160K 58,091
2020-10-03 Suri Anish President and CSO Option exercise +33,333 67,891
2020-10-03 Suri Anish President and CSO Option exercise · Restricted Stock Units −33,333 33,334
2020-09-30 Gray Cameron Director Purchase +5,000 $15.30 $77K 677,500
2020-09-29 Gray Cameron Director Purchase +5,000 $15.00 $75K 672,500
2020-09-17 HOWSON TAMAR D Director Grant or award · Stock Option (right to buy) +50,000 50,000
2020-08-24 Millar Kerri-Ann CFO Shares withheld for taxes −1,900 5,766
2020-08-21 Millar Kerri-Ann CFO Option exercise +6,666 7,666

Page 11 of 17 · 323 trades